Archive: General Page
-
Data Access
Georgetown University receives, stores, transmits, and uses data related to individuals’ health, medical conditions, and medical treatment in a wide variety of contexts, including conducting cutting-
Category: General Page
-
2019
This year’s 8th Annual Health Informatics and Data Science Symposium at Georgetown University offered a rich and varied program with spotlight talks by Dr. Laura Esserman of UCSF and Dr. Eric Peraksl
Category: General Page
-
ICBI Faculty and Staff
Adil Alaoui, MS, MBA Director, Health Information Technology and OperationsAdil Alaoui, Director of Health Information Technology and Operations, provides leadership, integrated management, and s
Category: General Page
-
ClinGen: First FDA- Approved Genomic Variants Database
We are part of the ClinGen network which is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes
Category: General Page
-
Detection of viral RNA in tumors (viGEN pipeline) on Cloud
The viGEN pipeline detects and quantifies viral RNA (and hence load) in human tumor samples Collaborators: Lombardi Experimental Therapeutics and Breast Cancer Programs Publications Usin
Category: General Page
-
The Georgetown Database of Cancer (G-DOC)
G-DOC was designed and engineered to be a unique multi-omics data analysis resource for translational cancer research. It currently integrates clinical, transcriptomic, metabolomic, and systems-level
Category: General Page
-
Technology for Tumor Boards & Trial Recruitment
We have developed the first ever, open source, cloud-based, asynchronous tumor board technology to enhance the utility of patient molecular profiling data from CLIA-certified/CAP-accredited molecular
Category: General Page
-
The Clinical Proteomics Tumor Analysis Consortium (CPTAC)- Data Center
The Clinical Proteomic Tumor Analysis Consortium (CPTAC) of NCI’s Office of Cancer Clinical Proteomics Research, is a comprehensive and coordinated effort to accelerate the understanding of the molec
Category: General Page
-
PanCAN Research Acceleration Network (RAN) Molecular Tailored Therapy
The goal of the PanCAN network was to study major changes in pancreatic cancer cells that are significantly associated with response and/or resistance to standard therapies. Collaborators: Lombard
Category: General Page
-
Human Factors and Usability of Molecular Reports
Eye-tracking studies help identify the strengths and weaknesses in content and form of molecular diagnostic (MDX) test reports which in turn inform clinical decision-making. Collaborators: MedStar
Category: General Page